Macronutrient intake, appetite, food preferences and exocrine pancreas function after treatment with short- and long-acting glucagon-like peptide-1 receptor agonists in type 2 diabetes
Improved Glycemic Control : Individuals with type 2 diabetes benefit immensely from the glucose-regulating effects of GLP-1 agonists, which enhance insulin secretion and inhibit glucagon production, promoting better glycemic control
Planning to eat every three hours and not going longer than 5 hours without eating is a good timeline to adopt
However, some studies also reported potential adverse effects, including mood disturbances and suicidal thoughts, leading to regulatory concerns and calls for further investigation
Only type 2 diabetes patients can switch
Gut hormones help to control hunger and satiety